Keywords
Systemic Arterial Hypertension
Mortality
Intensive Care Unit
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To correlate the presence of Systemic Arterial Hypertension in patients with COVID-19 admitted to the Intensive Care Unit of a hospital in Juiz de Fora – MG with the clinical outcome presented. Methods: This is an observational and cross-sectional study, in which 179 medical records of patients admitted with COVID-19 were analyzed in the Intensive Care Unit of a hospital in Juiz de Fora – MG, from June 2020 to January 2021. Results: Higher mortality rates were observed in older individuals. The presence of Systemic Arterial Hypertension and the patient's sex did not prove to be predictive factors of severity, as the ANOVA tests did not indicate a significant statistical difference. Conclusion: The highest risk of severe cases and deaths due to COVID-19 was observed in elderly individuals, which enables the development of appropriate professional conduct for this specific group, preventing unfavorable outcomes.
References
CHAN JFW, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient after visiting Wuhan. Emerging Microbes & Infections, 2020; 9(1): 221-236.
CHEN N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 2020; 395(10223): 507-513.
CHENCHULA S, et al. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression. Scientific Reports, 2023; 13(1):6415.
CUNHA DE OLIVEIRA ML e FERNANDES SILVA D. Epidemiologia da COVID-19: comparação entre boletins epidemiológicos. Com. Ciências Saúde [Internet]. 8º de maio de 2020 [citado 16º de fevereiro de 2024];31(Suppl1):61-74. Disponível em: https://revistaccs.escs.edu.br/index.php/comunicacaoemcienciasdasaude/article/view/661
DESSIE ZG e ZEWOTIR T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infectious Diseases, 2021; 21(1):855.
DU L, et al. The spike protein of SARS-CoV – a target for vaccine and therapeutic development. Natural Reviews Microbiology, 2009; 7(3): 226-236.
DU Y, et al. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 2021; 31(3): 745-755.
GALBAGE T, et al. Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes. Frontier Medicine (Lausanne), 2020; 7:348.
GENG J, et al. Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis. Frontier Medicine (Lausanne), 2021; 8: 588013.
GUIMARÃES-TEIXEIRA E, et al. Comorbidades e saúde mental dos trabalhadores da saúde no Brasil. O impacto da pandemia da COVID-19. Ciência & Saúde Coletiva, 2023; 28(10):2823-2832.
HOFFMANN M, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 2020; 181(2): 271-280.
HUANG C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 2020; 395(10223): 497-506.
MAHAMAT- SALEH Y, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open, 2021; 25;11(10):e052777.
NOOR FM e ISLAM MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. Journal of Community Health, 2020; 45(6):1270-1282.
RAVICHANDRAN B, et al. SARS-CoV-2 and hypertension. Physiological Reports, 2021; 9(11): 1-14.
SILVA, et al. FATORES INTERVENIENTES NO TEMPO DE INTERNAÇÃO HOSPITALAR DE PACIENTES COM COVID-19. Revista Enfermagem Atual In Derme, 2023; 97(2): e023084-e023084.
The jamovi project (2021). JAMOVI. (Version 2.2) [Computer Software]. Retrieved from https://www.jamovi.org.
World Health Organization. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Acessado em: 15 de Fevereiro de 2024.
WU F, et al. A new coronavirus associated with human respiratory disease in China. Nature, 2020; 579 (7798): 265-269.
ZHANG JJY, et al. Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19. A systematic review, meta-analysis, and meta-regression analysis. Clinical Infectious Diseases, 2020; 71(16): 2199-2206.